Home › Funds › THIRD AVENUE MANAGEMENT LLC › SUPN
THIRD AVENUE MANAGEMENT LLC position in SUPN
SUPERNUS PHARMACEUTICALS · Health Care
THIRD AVENUE MANAGEMENT LLC reported holding 157,150 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 1.14% of its reported portfolio and ranking #27 among its reported holdings. THIRD AVENUE MANAGEMENT LLC has disclosed SUPN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How THIRD AVENUE MANAGEMENT LLC's SUPN position evolved
THIRD AVENUE MANAGEMENT LLC first disclosed a stake in SUPN in Q3 2023 at 116,549 shares (US$3.3M). The position peaked in Q4 2025 at 189,493 shares, worth US$9.4M. Across 13 filings, THIRD AVENUE MANAGEMENT LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 157,150 shares valued at US$6.8M — an increase of 4,426 shares quarter over quarter.. Notable position changes include a 37% increase in Q4 2023 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 116.55K | $3.27M | New |
| Q4 2023 | 159.72K | $4.62M | Add |
| Q1 2024 | 159.72K | $5.45M | Hold |
| Q2 2024 | 189.12K | $5.06M | Add |
| Q3 2024 | 189.49K | $5.91M | Hold |
| Q4 2024 | 189.49K | $6.85M | Hold |
| Q1 2025 | 189.49K | $6.21M | Hold |
| Q2 2025 | 189.49K | $5.97M | Hold |
| Q3 2025 | 189.49K | $9.10M | Hold |
| Q4 2025 | 189.49K | $9.42M | Hold |
| Q1 2026 | 152.72K | $7.89M | Reduce |
| Q2 2026 | 152.72K | $7.10M | Hold |
| Q3 2026 | 157.15K | $6.76M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SUPN and 13F data
SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 34 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SUPN
- MILLENNIUM MANAGEMENT LLC 3.85M sh · $179.21M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.65M sh · $123.07M · Q2 2026
- Sofinnova Investments, Inc. 1.04M sh · $48.20M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 613.78K sh · $28.55M · Q2 2026
- Jones Hill Capital LP 601.68K sh · $25.90M · Q3 2026
- Soleus Capital Management, L.P. 520.00K sh · $24.19M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 490.22K sh · $22.80M · Q2 2026
More on THIRD AVENUE MANAGEMENT LLC
FAQ
How long has THIRD AVENUE MANAGEMENT LLC held SUPN?
THIRD AVENUE MANAGEMENT LLC has disclosed SUPN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is THIRD AVENUE MANAGEMENT LLC's current position in SUPN?
As of Q3 2026, THIRD AVENUE MANAGEMENT LLC holds 157.15K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $6.76M, representing 1.14% of its reported portfolio and ranking #27.
Has THIRD AVENUE MANAGEMENT LLC been buying or selling SUPN?
In the latest 13F filing (Q3 2026), THIRD AVENUE MANAGEMENT LLC increased its position in SUPN. The position peaked in Q4 2025 at 189.49K shares.
Which other funds hold SUPN?
Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.